Bild 1 von 1
Galerie
Bild 1 von 1
Mosby's Dental Drug Consult Ser.: Dental Drug Reference by Tommy W. Gage and...
US $5,00
Ca.EUR 4,30
Artikelzustand:
- Sofort-KaufenMosby's Dental Drug Consult Ser.: Dental Drug Reference by Tommy W. Gage and...
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Versand:
US $6,00 (ca. EUR 5,16) USPS Media MailTM.
Standort: White House, Tennessee, USA
Lieferung:
Lieferung zwischen Sa, 6. Dez und Mi, 10. Dez nach 94104 bei heutigem Zahlungseingang
Rücknahme:
30 Tage Rückgabe. Kostenloser Rückversand.
Zahlungen:
Sicher einkaufen
- Gratis Rückversand im Inland
- Punkte für jeden Kauf und Verkauf
- Exklusive Plus-Deals
Info zum Artikel
Der Verkäufer ist für dieses Angebot verantwortlich.
eBay-Artikelnr.:376714374740
Artikelmerkmale
- Artikelzustand
- Item Weight
- 1 lb 6 oz
- ISBN
- 9780323024778
Über dieses Produkt
Product Identifiers
Publisher
Elsevier-Health Sciences Division
ISBN-10
0323024777
ISBN-13
9780323024778
eBay Product ID (ePID)
2496209
Product Key Features
Number of Pages
912 Pages
Language
English
Publication Name
Dental Drug Reference
Subject
Dentistry / General
Publication Year
2003
Features
Revised
Type
Textbook
Subject Area
Medical
Series
Mosby's Dental Drug Consult Ser.
Format
Trade Paperback
Dimensions
Item Length
8.2 in
Item Width
5 in
Additional Product Features
Edition Number
6
Intended Audience
Scholarly & Professional
Table Of Content
Therapeutic/Pharmacologic Index Individual Drugs Appendixes A Selected abbreviations B Drugs causing dry mouth C Controlled substances chart D FDA pregnancy categories E Drugs affecting taste F Selected drug combination products G Dose calculations by weight H Herbal and nonherbal remedies I Drugs affecting CYP450 enzymes J Sample prescriptions K Selected references Generic and Trade Name Index New drug updates 2003
Edition Description
Revised edition
Synopsis
Designed to be used chairside in the dental office, this quick, concise resource assists in the rapid identification of drugs that patients may be taking as they present in the dental office. The revised reprint of the sixth edition contains an insert at the back of the book -New Drug Updates 2003 - that includes monographs of the new drugs that have received FDA approval since the publication of Mosby's Dental Drug Reference, 6th Edition. These monographs follow the same format as those in the main part of the book. They are arranged in alphabetical order by generic name, and trade names are given for all medications in common use. Each monograph contains the same subsections as those listed and described in the main part of the book., Designed to be used chairside in the dental office, this quick, concise resource assists in the rapid identification of drugs that patients may be taking as they present in the dental office. The revised reprint of the sixth edition contains an insert at the back of the book -New Drug Updates 2003 - that includes monographs of the new drugs that have received FDA approval since the publication of Mosby''s Dental Drug Reference, 6th Edition. These monographs follow the same format as those in the main part of the book. They are arranged in alphabetical order by generic name, and trade names are given for all medications in common use. Each monograph contains the same subsections as those listed and described in the main part of the book. Highlights oral side effects with dental alert icons. Designates interactions of concern to dentistry with drug interaction icons. Indicates common brand names for generic drugs sold only in Canada with Maple leaf icons. Provides information on the top 200 prescription drugs in the United States. Includes complete and consistent monographs of more than 2000 commonly used drug products. Focuses on drug interactions of clinical interest. Offers updates of new drugs, as approved, on Mosby''s web site: www.mosby.com/dental Includes 11 useful appendixes. Provides a therapeutic/pharmacologic index. Includes the recommended antibiotic prophylaxis for the prevention of bacterial endocarditis as detailed by the American Heart Association. Covers the recommended antibiotic prophylaxis for the prevention of prosthetic joint infection. Each drug profiled includes: generic name of the drug, presented alphabetically with pronunciation common brand names for the generic drug as sold in the U.S. and Canada, with designations for drugs sold only in Canada (Maple leaf icon) drug class, to facilitate drug identification controlled substances schedule as appropriate for the U.S. and Canada action, providing a brief description of the mechanism of action of the drug uses or indications for the drug, including those approved by the FDA. Unapproved uses are identified as appropriate for selected drugs doses and routes of administration, to assist in assessing the dose in relationship to the seriousness of the patient''s disease and for predicting potential side effects and drug interactions side effects/adverse reactions grouped according to body systems. Common side effects are listed in italics; life-threatening reactions are in boldface, italic type. Information regarding oral manifestations of side effects is listed separately. contraindications in which the medication should absolutely not be given or when risk/benefit criteria must be established precautions to be considered when prescribing and using the drug, along with identification of pregnancy categories pharmacokinetics, briefly described for each drug drug interactions of concern to dentistry, helping you exercise clinical judgment regarding both beneficial and harmful interactions dental considerations, including general information, suggestions for medical consultations, and recommendations for the patient/family in preventing dental complications A 16-page, New Drug Updates 2003 insert includes monographs of drugs that have received recent FDA approval. Coverage includes more than 40 new Federally approved drugs through 2002. All new and existing drug monographs have been reviewed for accuracy and currency on usage and dosage information. Additional alternative therapies help those who encounter patients taking an increasing number of complementary and alternative medicines. Two NEW appendixes have been added: Drugs affecting CYP450 enzymes and Sample prescriptions. A companion CD-ROM contains 30 full-color pathologic conditions that may result from drugs patients are taking, as well as 115 customizable patient education sheets that provide patients with invaluable drug information and specific instructions in both English and Spanish., Designed to be used chairside in the dental office, this quick, concise resource assists in the rapid identification of drugs that patients may be taking as they present in the dental office. The revised reprint of the sixth edition contains an insert at the back of the book -New Drug Updates 2003 - that includes monographs of the new drugs that have received FDA approval since the publication of Mosby's Dental Drug Reference, 6th Edition. These monographs follow the same format as those in the main part of the book. They are arranged in alphabetical order by generic name, and trade names are given for all medications in common use. Each monograph contains the same subsections as those listed and described in the main part of the book. Highlights oral side effects with dental alert icons. Designates interactions of concern to dentistry with drug interaction icons. Indicates common brand names for generic drugs sold only in Canada with Maple leaf icons. Provides information on the top 200 prescription drugs in the United States. Includes complete and consistent monographs of more than 2000 commonly used drug products. Focuses on drug interactions of clinical interest. Offers updates of new drugs, as approved, on Mosby's web site: www.mosby.com/dental Includes 11 useful appendixes. Provides a therapeutic/pharmacologic index. Includes the recommended antibiotic prophylaxis for the prevention of bacterial endocarditis as detailed by the American Heart Association. Covers the recommended antibiotic prophylaxis for the prevention of prosthetic joint infection. Each drug profiled includes: generic name of the drug, presented alphabetically with pronunciation common brand names for the generic drug as sold in the U.S. and Canada, with designations for drugs sold only in Canada (Maple leaf icon) drug class, to facilitate drug identification controlled substances schedule as appropriate for the U.S. and Canada action, providing a brief description of the mechanism of action of the drug uses or indications for the drug, including those approved by the FDA. Unapproved uses are identified as appropriate for selected drugs doses and routes of administration, to assist in assessing the dose in relationship to the seriousness of the patient's disease and for predicting potential side effects and drug interactions side effects/adverse reactions grouped according to body systems. Common side effects are listed in italics; life-threatening reactions are in boldface, italic type. Information regarding oral manifestations of side effects is listed separately. contraindications in which the medication should absolutely not be given or when risk/benefit criteria must be established precautions to be considered when prescribing and using the drug, along with identification of pregnancy categories pharmacokinetics, briefly described for each drug drug interactions of concern to dentistry, helping you exercise clinical judgment regarding both beneficial and harmful interactions dental considerations, including general information, suggestions for medical consultations, and recommendations for the patient/family in preventing dental complications A 16-page, New Drug Updates 2003 insert includes monographs of drugs that have received recent FDA approval. Coverage includes more than 40 new Federally approved drugs through 2002. All new and existing drug monographs have been reviewed for accuracy and currency on usage and dosage information. Additional alternative therapies help those who encounter patients taking an increasing number of complementary and alternative medicines. Two NEW appendixes have been added: Drugs affecting CYP450 enzymes and Sample prescriptions. A companion CD-ROM contains 30 full-color pathologic conditions that may result from drugs patients are taking, as well as 115 customizable patient education sheets that provide patients with invaluable drug information and specific instructions in both English and Spanish.
LC Classification Number
RK701
Artikelbeschreibung des Verkäufers
Info zu diesem Verkäufer
White House General Store
100% positive Bewertungen•7.846 Artikel verkauft
Angemeldet als privater VerkäuferDaher finden verbraucherschützende Vorschriften, die sich aus dem EU-Verbraucherrecht ergeben, keine Anwendung. Der eBay-Käuferschutz gilt dennoch für die meisten Käufe. Mehr erfahrenMehr erfahren
Verkäuferbewertungen (4.257)
- 2***b (849)- Bewertung vom Käufer.Letzter MonatBestätigter KaufGreat item with excellent value! Packaged well as it arrived in perfect condition. The shipping was very quick and the communication was great! Highly recommended seller! Thanks again!
- s***m (303)- Bewertung vom Käufer.Letzter MonatBestätigter KaufI'm late with this feedback. The book is just as it was described. Shipping was quick and the book is in excellent condition. An easy transaction that reminded me why I continue to use eBay.
- 3***o (160)- Bewertung vom Käufer.Letzter MonatBestätigter KaufFast shipping and product as described. Great seller!! A++